BR112014014278A2 - composição farmacêutica - Google Patents

composição farmacêutica

Info

Publication number
BR112014014278A2
BR112014014278A2 BR112014014278A BR112014014278A BR112014014278A2 BR 112014014278 A2 BR112014014278 A2 BR 112014014278A2 BR 112014014278 A BR112014014278 A BR 112014014278A BR 112014014278 A BR112014014278 A BR 112014014278A BR 112014014278 A2 BR112014014278 A2 BR 112014014278A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
simethicone
mannitol
calcium phosphate
relates
Prior art date
Application number
BR112014014278A
Other languages
English (en)
Inventor
Rajesh Tendulkar Anjali
Anilkant Doshi Hiteshkumar
Luis Velada José
Shinde Vicky
Original Assignee
Disphar Int B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Disphar Int B V filed Critical Disphar Int B V
Publication of BR112014014278A2 publication Critical patent/BR112014014278A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

resumo composição farmacêutica a presente invenção refere-se a formulações farmacêuticas sólidas com base em simeticona, fosfato de cálcio e manitol.
BR112014014278A 2011-12-14 2012-12-11 composição farmacêutica BR112014014278A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11193452 2011-12-14
PCT/NL2012/050879 WO2013095111A1 (en) 2011-12-14 2012-12-11 Simethicone formulation

Publications (1)

Publication Number Publication Date
BR112014014278A2 true BR112014014278A2 (pt) 2017-06-13

Family

ID=47628413

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014014278A BR112014014278A2 (pt) 2011-12-14 2012-12-11 composição farmacêutica

Country Status (8)

Country Link
US (1) US20150119422A1 (pt)
EP (1) EP2790676B1 (pt)
AU (1) AU2012327176B2 (pt)
BR (1) BR112014014278A2 (pt)
CA (1) CA2858821A1 (pt)
IN (1) IN2014MN01382A (pt)
RU (1) RU2602745C2 (pt)
WO (1) WO2013095111A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA41620A (fr) 2015-05-14 2018-01-09 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Composition pharmaceutique comprenant de la siméthicone et de l'otilonium
EP3294269A1 (en) 2015-06-12 2018-03-21 Santa Farma Ilaç Sanayi A.S. Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics
MX2016016587A (es) * 2016-12-14 2018-06-13 Rhein Siegfried Sa De Cv Composicion mejorada de lansoprazol y simeticona y procesos para prepararla.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US6103260A (en) 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
US6793934B1 (en) 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
US7101573B2 (en) 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
WO2007057924A1 (en) 2005-11-21 2007-05-24 Panacea Biotec Ltd Laxative composition on the basis of triphala
WO2008056200A1 (en) * 2006-11-10 2008-05-15 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of simethicone

Also Published As

Publication number Publication date
IN2014MN01382A (pt) 2015-04-17
RU2014128604A (ru) 2016-02-10
CA2858821A1 (en) 2013-06-27
AU2012327176A1 (en) 2013-07-04
AU2012327176B2 (en) 2015-08-13
US20150119422A1 (en) 2015-04-30
RU2602745C2 (ru) 2016-11-20
EP2790676A1 (en) 2014-10-22
WO2013095111A1 (en) 2013-06-27
EP2790676B1 (en) 2018-01-10

Similar Documents

Publication Publication Date Title
JOP20180102B1 (ar) مركب صيدلاني
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
BR112015028853A2 (pt) Composição detergente com ph baixo
BR112015000329A2 (pt) formulações de diclofenac
EA201492160A1 (ru) Композиции, содержащие бензодиазепины короткого действия
BR112014025041B8 (pt) Composição farmacêutica
BR112015022095A2 (pt) formulações eutéticas de cloridrato de ciclobenzaprina e cloridrato de amitriptilina
BR112012019997A2 (pt) composições de cuidado oral
BR112014031310A2 (pt) anticorpos anti-pcsk9, formulações, dosagem e métodos de uso
EA201200617A1 (ru) Полимеры на основе циклодекстрина для доставки лекарственных средств
BR112015001414A2 (pt) composição antideriva
UY4281Q (es) Juguera
EA201390613A1 (ru) Обогащенный дейтерием расагилин
BR112013004016A2 (pt) formulações á base de nalbufina e as respectivas utilizações
JO3154B1 (ar) عوامل مضادة لـ trpv4
TR201905787T4 (tr) Liyofilize TAT-NR2B9C formülasyonu.
EA201600442A1 (ru) Мягкая фармацевтическая композиция на водной основе, содержащая тапентадол
CO7160080A2 (es) Composiciones lipídicas de racecadotrillo
MA35816B1 (fr) Dérivés d'aniline, leur préparation et leur application thérapeutique
EA201300733A1 (ru) Рекомбинантные микобактерии в качестве вакцины
BR112015009301A2 (pt) biocontrole de nematoides
CL2009000904A1 (es) Compuestos derivados de ciclohexil sulfonamidas que tienen actividad antagonista en el receptor npy y5, composicion farmaceutica y formulacion farmaceutica que los comprende.
EA201590790A1 (ru) СТАБИЛЬНАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ PEG-ИНТЕРФЕРОНА АЛЬФА-2b
CR11755A (es) Dronedarona para la prevencion de la cardioversion
BR112014014278A2 (pt) composição farmacêutica

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2494 DE 23-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B350 Update of information on the portal [chapter 15.35 patent gazette]